Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2005 May;90(3):F240–F244. doi: 10.1136/adc.2004.057570

UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome

L Haines, A Fielder, H Baker, A Wilkinson
PMCID: PMC1721880  PMID: 15846016

Abstract

Background: Retinopathy of prematurity (ROP) is one of the few causes of childhood blindness in which severe vision impairment is largely preventable. Ophthalmic screening for ROP is required to identify disease that requires treatment whereby the development of potentially blinding disease can be minimised.

Objectives: To make the first UK population based estimate of the incidence of babies with severe ROP (stage 3 or more); to document their clinical characteristics and management and to evaluate the appropriateness of current ROP screening guidelines in the UK.

Patients: Cases were recruited through a national surveillance programme with 1 year ophthalmic follow up and data from clinician completed questionnaires.

Results: Between 1 December 1997 and 31 March 1999, 233 preterm babies with stage 3 ROP were identified. Severity (location, extent, and presence of plus disease) was associated with degree of prematurity, most severe in the most premature babies. Fifty nine percent were treated. The UK screening protocol was followed in two thirds of cases, but in the remainder it was begun too late or was too infrequent. Three quarters of the cases were followed up at 1 year, and 13% had a severe vision deficit as a result of ROP.

Conclusions: Visual deficit as a result of ROP in premature babies continues to be a severe disability in some of the survivors of neonatal intensive care. Further efforts are needed to organise treatment regionally to improve outcome and standards of practice.

Full Text

The Full Text of this article is available as a PDF (76.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andruscavage L., Weissgold D. J. Screening for retinopathy of prematurity. Br J Ophthalmol. 2002 Oct;86(10):1127–1130. doi: 10.1136/bjo.86.10.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brennan R., Gnanaraj L., Cottrell D. G. Retinopathy of prematurity in practice. I: screening for threshold disease. Eye (Lond) 2003 Mar;17(2):183–188. doi: 10.1038/sj.eye.6700296. [DOI] [PubMed] [Google Scholar]
  3. Darlow B. A. Incidence of retinopathy of prematurity in New Zealand. Arch Dis Child. 1988 Sep;63(9):1083–1086. doi: 10.1136/adc.63.9.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Early Treatment For Retinopathy Of Prematurity Cooperative Group Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003 Dec;121(12):1684–1694. doi: 10.1001/archopht.121.12.1684. [DOI] [PubMed] [Google Scholar]
  5. Fielder A. R., Haines L., Scrivener R., Wilkinson A. R., Pollock J. I., Royal Colleges of Ophthalmologists and Paediatrics and Child Health, and the British Association of Perinatal Medicine Retinopathy of prematurity in the UK II: audit of national guidelines for screening and treatment. Eye (Lond) 2002 May;16(3):285–291. doi: 10.1038/sj.eye.6700131. [DOI] [PubMed] [Google Scholar]
  6. Fielder A. R., Shaw D. E., Robinson J., Ng Y. K. Natural history of retinopathy of prematurity: a prospective study. Eye (Lond) 1992;6(Pt 3):233–242. doi: 10.1038/eye.1992.46. [DOI] [PubMed] [Google Scholar]
  7. Fleck B. W., Wright E., Dhillon B., Millar G. T., Laing I. A. An audit of the 1995 Royal College of Ophthalmologists guidelines for screening for retinopathy of prematurity applied retrospectively in one regional neonatal intensive care unit. Eye (Lond) 1995;9(Pt 6 SU):31–35. [PubMed] [Google Scholar]
  8. Foot B., Stanford M., Rahi J., Thompson J., British Ophthalmological Surveillance Unit Steering Committee The British Ophthalmological Surveillance Unit: an evaluation of the first 3 years. Eye (Lond) 2003 Jan;17(1):9–15. doi: 10.1038/sj.eye.6700233. [DOI] [PubMed] [Google Scholar]
  9. Gilbert C., Rahi J., Eckstein M., O'Sullivan J., Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997 Jul 5;350(9070):12–14. doi: 10.1016/S0140-6736(97)01107-0. [DOI] [PubMed] [Google Scholar]
  10. Goble R. R., Jones H. S., Fielder A. R. Are we screening too many babies for retinopathy of prematurity? Eye (Lond) 1997;11(Pt 4):509–514. doi: 10.1038/eye.1997.136. [DOI] [PubMed] [Google Scholar]
  11. Haines L., Fielder A. R., Scrivener R., Wilkinson A. R., Royal College of Paediatrics and Child Health, the Royal College of Ophthalmologists and British Association of Perinatal Medicine Retinopathy of prematurity in the UK I: the organisation of services for screening and treatment. Eye (Lond) 2002 Jan;16(1):33–38. doi: 10.1038/sj.eye.6700030. [DOI] [PubMed] [Google Scholar]
  12. Larsson E., Carle-Petrelius B., Cernerud G., Ots L., Wallin A., Holmström G. Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol. 2002 Oct;86(10):1122–1126. doi: 10.1136/bjo.86.10.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lee S. K., Normand C., McMillan D., Ohlsson A., Vincer M., Lyons C., Canadian Neonatal Network Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med. 2001 Mar;155(3):387–395. doi: 10.1001/archpedi.155.3.387. [DOI] [PubMed] [Google Scholar]
  14. Mathew M. R. K., Fern A. I., Hill R. Retinopathy of prematurity: are we screening too many babies? Eye (Lond) 2002 Sep;16(5):538–542. doi: 10.1038/sj.eye.6700031. [DOI] [PubMed] [Google Scholar]
  15. O'Connor Anna R., Stephenson Terence, Johnson Ann, Tobin Michael J., Moseley Merrick J., Ratib Sonia, Ng Yin, Fielder Alistair R. Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics. 2002 Jan;109(1):12–18. doi: 10.1542/peds.109.1.12. [DOI] [PubMed] [Google Scholar]
  16. Palmer E. A., Flynn J. T., Hardy R. J., Phelps D. L., Phillips C. L., Schaffer D. B., Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991 Nov;98(11):1628–1640. doi: 10.1016/s0161-6420(91)32074-8. [DOI] [PubMed] [Google Scholar]
  17. Rahi J. S., Dezateux C. Epidemiology of visual impairment in Britain. Arch Dis Child. 1998 Apr;78(4):381–386. doi: 10.1136/adc.78.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rahi Jugnoo S., Cable Noriko, British Childhood Visual Impairment Study Group Severe visual impairment and blindness in children in the UK. Lancet. 2003 Oct 25;362(9393):1359–1365. doi: 10.1016/S0140-6736(03)14631-4. [DOI] [PubMed] [Google Scholar]
  19. Reynolds James D., Dobson Velma, Quinn Graham E., Fielder Alistair R., Palmer Earl A., Saunders Richard A., Hardy Robert J., Phelps Dale L., Baker John D., Trese Michael T. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol. 2002 Nov;120(11):1470–1476. doi: 10.1001/archopht.120.11.1470. [DOI] [PubMed] [Google Scholar]
  20. Wood N. S., Marlow N., Costeloe K., Gibson A. T., Wilkinson A. R. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000 Aug 10;343(6):378–384. doi: 10.1056/NEJM200008103430601. [DOI] [PubMed] [Google Scholar]
  21. Wright K., Anderson M. E., Walker E., Lorch V. Should fewer premature infants be screened for retinopathy of prematurity in the managed care era? Pediatrics. 1998 Jul;102(1 Pt 1):31–34. doi: 10.1542/peds.102.1.31. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES